OUR PLATFORM

Human tissues that solve the 95% clinical trial failure rate.

Revolutionary biomaterial 3D printing technology that recreates the complex functions and behaviors of native human organs at scale.

THE CHALLENGE

Current preclinical models bottleneck therapeutic discovery.

Non-Translatable

Current animal models fail to predict human outcomes

Slow & Laborious

Lengthy development cycles delay drug discovery

Limited Throughput

Low-volume testing restricts research capacity

High Cost

Expensive infrastructure and maintenance overhead

THE SOLUTION

Nanocellic Platform

By testing on lab-grown human organ tissues at scale, we enable faster, more accurate drug discovery.

Human-Relevant Models

Lab-grown human tissues that accurately replicate organ function and disease responses

Accelerated Timeline

Dramatically reduce drug development cycles from years to months

High-Throughput Testing

Test thousands of compounds simultaneously with consistent, reproducible results

Cost-Effective

Reduce preclinical research expenses while improving accuracy and reliability

PLATFORM FEATURES

Comprehensive capabilities for modern research

3D Microfluidics

Advanced microfluidic technology creates physiologically relevant tissue environments

Multi-Organ Models

Comprehensive suite of organ models including lung, liver, brain, and intestine

Real-Time Monitoring

Continuous data collection and analysis for dynamic tissue behavior insights

Scalable Platform

Easily scale from single-tissue studies to complex multi-organ interactions

Data Integration

Seamless integration with your existing research workflows and databases

Regulatory Support

Documentation and validation support for regulatory submissions

Ready to revolutionize your research?

Get in touch with our team to learn how Nanocellic can accelerate your drug discovery process.